Obesity Capsule Maker Wants $60M IPO After $22M Financing
Gelesis Inc. filed for a $60 million initial public offering on Wednesday, the same day it secured $22 million in private financing, as it continues testing a new obesity treatment....To view the full article, register now.
Already a subscriber? Click here to view full article